The research company Chosa Oncology announces the outcome of the exercise of warrants of series TO2. A total of just under 3.6 million warrants were exercised, corresponding to approximately 45 percent of the total number of outstanding warrants.Through the exercise, the company receives approximately SEK 2.8 million before transaction costs.